Loading data for AMRN — first visit, this takes a few seconds.
Amarin Corporation plc (AMRN)
NasdaqCM: AMRN
· 即時價格 · USD
13.63
-0.08 (-0.58%)
收盤價: Sep 04, 2026, 3:59 PM
13.66
+0.22%
盤後: 7:42 PM
股價、關鍵數字和最新消息,都在這一頁。
Amarin Corporation plc(AMRN)股價、分析與資料
-0.58% (1D)
| 買價 | 11.52 |
| 市值 | 288M |
| 營收 (ttm) | 186M |
| 淨利(ttm) | -27.1M |
| 0.76 | |
| -1.2 | |
| n/a | |
| 13.91 | |
| P/B (ttm) | 0.65 |
| P/S (ttm) | 1.53 |
| 財報日期 | Apr 29, 2021 |
| 賣價 | 15.6 |
| 成交量 | 80,471 |
| 20 日平均成交量 | 79,130 |
| 開盤價 | 13.84 |
| 前收盤價 | 13.71 |
| 當日區間 | 13.52 - 13.85 |
| 52 週範圍 | 12.96 - 20.90 |
| 分析師 | n/a |
| 目標價 | n/a |
| 股利 | n/a |
| 除息日 | n/a |
關於 AMRN
Amarin Corporation plc, a pharmaceutical company, engages in the commercialization and development of therapeutics for the treatment of cardiovascular diseases in the United States, Europe, and internationally. It offers VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. The company sells its products principally through wholesale...
完整的公司簡介財報驚奇
Amarin plc 已於 Jul 29, 2026 公布季度財報:
- 營收為 $42.21M 低於預期 $0, 年增 -41.97% 下滑.
- 每股盈餘為 -0.02 低於預期 -0.01, 年增 95.00% 成長.
第 1 頁,共 2 頁

